Skip to main content

Table 2 OCT features of eyes with steroid induced CSC (group A) and those with idiopathic CSC (group B)

From: Retinal and choroidal changes in steroid-associated central serous chorioretinopathy

 

Group A N = 20 eyes

Group B N = 30 eyes

P value

OR (95% CI)

P value

CMT (µm ± SD)

370.25 ± 156.39

484.63 ± 222.02

0.08

–

–

NSD height (µm ± SD)

153.1 ± 175.70

312.9 ± 223.06

< 0.01*

–

–

Subretinal deposits

4/20 (20%)

12/30 (40%)

0.22

0.38 (0.10–1.40)

0.14

RPE irregularities

5/20 (25%)

5/30 (16.67%)

0.49

1.67 (0.41–6.73)

0.47

PED

5/20 (25%)

11/30 (36.67%)

0.54

0.58 (0.16–2.02)

0.39

Double layer sign

4/20 (20%)

11/30 (36.67%)

0.35

0.43 (0.11–1.62)

1.24

Outer retinal layer disruption

0/20 (0%, 95% CI, 0–16.11%)

2/30 (6.67%)

0.51

0.28 (0.01–6.10)

0.42

Hyperreflective dots

3/20 (15%)

14/30 (46.67%)

0.03*

0.20 (0.05–0.84)

0.03*

Intraretinal fluid

0/20 (0%, 95% CI, 0–16.11%)

2/30 (6.67%)

0.51

0.28 (0.01–6.10)

0.42

SFCT (µm ± SD)

359.4 ± 49.10

355.53 ± 50.42

0.65

–

–

SLCVD (µm ± SD)

162.8 ± 39.01

163.38 ± 49.26

0.78

–

–

CVI

82 ± 35%

58 ± 3%

0.10

–

–

  1. OCT optical coherence tomography; CMT central macular thickness; NSD neurosensory detachment; RPE retinal pigment epithelium; PED pigment epithelial detachment; CT choroidal thickness; SLCVD subfoveal large choroidal vessel diameter; CVI choroidal vascularity index; OR odds ratio; CI confidence interval
  2. * Statistically significant